share_log

HC Wainwright & Co. Reiterates Buy on Poseida Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. Reiterates Buy on Poseida Therapeutics, Maintains $20 Price Target

HC Wainwright & Co.重申买入Poseida Therapeutics,维持20美元的目标股价
Benzinga ·  04/22 06:40

HC Wainwright & Co. analyst Arthur He reiterates Poseida Therapeutics (NASDAQ:PSTX) with a Buy and maintains $20 price target.

HC Wainwright & Co. 分析师亚瑟·何重申 Poseida Therapeutics(纳斯达克股票代码:PSTX)的买入并维持20美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发